Filing status
- Accounts due
- 27 December 2026
- Last accounts
- 27 March 2025
- Conf. stmt due
- 23 October 2027
- Last conf. stmt
- 9 October 2026
Nephro-Urology Clinical Trials Ltd.
- Incorporated
- 9 October 2002 (24 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Owned by
- Accounts type
- Total exemption full
- Region
- East of England
- Address
- 1 Tower HouseTower CentreHoddesdonEN11 8UR
Officers 2 active
Officer details are public data from the Companies House register.
Secretary · Appointed 9 October 2002
British
Director · Appointed 9 October 2002
British
Born September 1954 (72)
Officer history (3 former)
20 January 2010
Resigned Evans, Olwen Kathleen as Director
9 October 2002
9 October 2002
9 October 2002
9 October 2002
9 October 2002
9 October 2002
9 October 2002
Appointed Evans, Olwen Kathleen as Director
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 18 December 2018
Owns 75–100% of shares
Holds 75–100% of voting rights
Limited Company
Reg. no. 11044713
Former controllers (1)
18 December 2018
Group structure 7 companies
Ownership group derived from the Companies House PSC register
Nephro-Urology Clinical Trials Ltd. This company Owns 75–100% of shares
Queen Anne Street Medical Centre Limited Owns 75–100% of shares
Essex Health Care Alliance Limited Owns 75–100% of shares
Queen Anne Street Essex Medical Limited Owns 50–75% of shares
Respiratory Clinical Trials Limited Owns 75–100% of shares
The Heart Lung Centre Limited Owns 50–75% of shares
Financials
Balance sheet as at 27 March 2025 · total exemption full accounts
- Cash
- £922
- Current Ratio
- 0.7x
Trend
Shareholder Funds
Balance sheet detail
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Current Assets | £551,146 | £551,498 | £551,857 | £306,970 | £245,134 | £10,378 |
| Debtors | £550,224 | £550,224 | £550,224 | £290,970 | £1 | £9,968 |
| Cash | £922 | £1,274 | £1,633 | £16,000 | £245,133 | £410 |
| Creditors (< 1 year) | £761,592 | £750,864 | £750,863 | £492,620 | £416,357 | £170,465 |
| Net Current Assets | (£210,446) | (£199,366) | (£199,006) | (£185,650) | (£171,223) | (£160,087) |
| Shareholder Funds | (£210,446) | (£199,366) | (£199,006) | (£185,650) | (£171,223) | (£160,087) |
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 23 March 2026 | Total exemption full accounts | 27 March 2025 | ||
| 23 December 2025 | Previous accounting period shortened | |||
| 10 October 2025 | Confirmation statement with updates | 9 October 2025 | ||
| 23 December 2024 | Total exemption full accounts | 31 March 2024 | ||
| 11 October 2024 | Confirmation statement with updates | 9 October 2024 |
Some other companies at this address
Other companies in this industry
Cambridge
Chalgrove
Runcorn
Altrincham
Manchester
Liverpool
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →